83 Another phase 3 multicenter, double-blind, randomized study concluded that saroglitazar at 4 mg for 52 weeks improved NAS score, transaminitis, and lipid profile without fibrosis worsening [Abstract 1427, APASL liver meet 2020 Hepatol Int (2020) 14 (Suppl 1): S326]
10.1016/j.ebiom.2020.102810 [DOI] [PMC free article] [PubMed] [Google Scholar] Okhovat JP, Marks DH, Manatis-Lornell A et al (2023) Association between alopecia areata, anxiety, and depression: a systematic review and meta-analysis
G.PosarA.ParmeggianiA.PipitoneE.DAgataM
The results, published in The New England Journal of Medicine in September 2025, showed that orforglipron is safe and effective for weight lossand offers additional cardiovascular benefits
Ro Launches Wegovy Pill Through Integration with Novo Nordisk Ro to play critical role in ensuring patients nationwide get access to first and only oral GLP-1 weight loss medication at the lowest available cash price January 5, 2026 -- Ro, the leading direct-to-patient healthcare company, announced today that it is working with Novo Nordisk on the nationwide launch of the new Wegovy pill
For a simple explanation of the format, you can also read our page on All About Liposomes
